Amyloid β Protein in Plasma as a Diagnostic Marker for Alzheimer’s Disease

This publication has 14 references indexed in Scilit:

• The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)
  Neurology, 1997
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
  Neuron, 1996
• Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
  Annals of Neurology, 1995
• Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease
  Annals of Neurology, 1995
• Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus
  Science, 1995
• Long Amyloid .beta.-Protein Secreted from Wild-Type Human Neuroblastoma IMR-32 Cells
  Biochemistry, 1995
• Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
  Annals of Neurology, 1995
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
  Neuron, 1994
• The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
  Biochemistry, 1993
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984